Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Safety board OKs continuation of pivotal GTx cancer trials
GTx is evaluating the use of Acapodene (toremifene citrate) in an 80mg dose for the treatment of multiple side effects of androgen deprivation therapy (ADT) in men with
GTx is evaluating the use of Acapodene (toremifene citrate) in an 80mg dose for the treatment of multiple side effects of androgen deprivation therapy (ADT) in men with
NI-0401 is a fully human antibody that targets the CD3 antigen, a key regulator in the activation of T-cells. The proliferation of activated T-cells is a hallmark of
For the full year, Novartis’ net sales rose 14% to $32.2 billion. This increase was thanks to expansion in the company’s pharmaceuticals and Sandoz divisions, and was supported
The clinical trial (Study 934) compared a treatment regimen of Viread (tenofovir disoproxil fumarate), Emtriva (emtricitabine) and Sustiva (efavirenz) to a regimen of Combivir (lamivudine/zidovudine) with Sustiva in
Under the terms of the agreement, Galapagos’ service division BioFocus will perform medicinal chemistry services on a series of Cancer Research Technology (CRT) anticancer drug programs. In return,
SPP100 (aliskiren), which is expected to launch under the trade name Rasilez, was tested on its own and in co-administration with amlodipine (a calcium channel blocker) and ramipril
The University of Essen is the primary trial site for the phase IIa clinical trial which is designed to assess the activity and safety of ATL1102 in 80
The results from a two-year phase II/III clinical trial of Tolamba, a ragweed allergy immunotherapeutic, showed that patients treated with the drug experienced a statistically significant reduction in
The new agreement will use Caprion’s CellCarta proteomics discovery platform which comprehensively profiles the expression and identity of proteins detected in tissues and blood plasma. The company is
This trial will assess the efficacy and safety of the study drug in an at-risk patient population. Work on the study is expected to begin immediately. Covalent will